Satomi Niwayama - Publications
Affiliations: | Muroran Institute of Technology |
Year | Citation | Score | |||
---|---|---|---|---|---|
2010 | NIWAYAMA S, LOH C, TURK BE, LIU JO, MIYACHI H, HASHIMOTO Y. ChemInform Abstract: Enhanced Potency of Perfluorinated Thalidomide Derivatives for Inhibition of LPS-Induced Tumor Necrosis Factor-α Production is Associated with a Change of Mechanism of Action. Cheminform. 29: no-no. DOI: 10.1002/CHIN.199836166 | 0.627 | |||
1998 | Niwayama S, Loh C, Turk BE, Liu JO, Miyachi H, Hashimoto Y. Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-α production is associated with a change of mechanism of action Bioorganic and Medicinal Chemistry Letters. 8: 1071-1076. PMID 9871710 DOI: 10.1016/S0960-894X(98)00171-1 | 0.594 | |||
1998 | Griffith EC, Zhuang SU, Niwayama S, Ramsay CA, Chang YH, Liu JO. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2 Proceedings of the National Academy of Sciences of the United States of America. 95: 15183-15188. PMID 9860943 DOI: 10.1073/Pnas.95.26.15183 | 0.431 | |||
1998 | Miyachi H, Koiso Y, Shirai R, Niwayama S, Liu JO, Hashimoto Y. Tumor necrosis factor-alpha production enhancing activity of substituted 3'-methylthalidomide: Influence of substituents at the phthaloyl moiety on the activity and stereoselectivity Chemical and Pharmaceutical Bulletin. 46: 1165-1168. PMID 9692223 DOI: 10.1248/Cpb.46.1165 | 0.671 | |||
1996 | Niwayama S, Turk BE, Liu JO. Potent inhibition of tumor necrosis factor-α production by tetrafluorothalidomide and tetrafluorophthalimides Journal of Medicinal Chemistry. 39: 3044-3045. PMID 8759624 DOI: 10.1021/Jm960284R | 0.704 | |||
Show low-probability matches. |